Colleague Fahd Al-Wathinani, editor of Al-Manqatil newspaper, was saddened by the death of his uncle Qatim bin Nami bin Jafin, and he will be prayed for tomorrow (Monday) at Al-Abbas Mosque in Taif, and burial will be in Al-Sudaira.
Okaz (Mecca)
Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Colleague Fahd Al-Wathinani, editor of Al-Manqatil newspaper, was saddened by the death of his uncle Qatim bin Nami bin Jafin, and he will be prayed for tomorrow (Monday) at Al-Abbas Mosque in Taif, and burial will be in Al-Sudaira.
Okaz (Mecca)
Biopharmaceutical firms are leveraging automated synthesis platforms to target previously undruggable intracellular pathway proteins.
Pharmaceutical majors are reallocating research capital toward metabolic disease treatments, curtailing funding for earlier-stage oncology programs.
Pharmaceutical adoption rates for metabolic therapies are reshaping long-term forecasts for cardiovascular and chronic care spending.
Health authorities are introducing post-market surveillance mandates for algorithmic diagnostic software to track real-world clinical accuracy and drift.
Biotechnology firms prioritize precision genetic interventions for rare metabolic and autoimmune conditions.
Computational biology platforms reduce early-stage candidate screening times from years to months.